CoChat

Redox Balance in the Pathogenesis of Nonalcoholic Fatty Liver Disease: Mechanisms and Therapeutic Opportunities

Gambino, Roberto, Musso, Giovanni, Cassader, Maurizio · 2011 · Antioxidants & Redox Signaling
Cited by 147

The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.

Abstract

Nonalcoholic fatty liver disease (NAFLD) is currently the most common liver disease in the world. It encompasses a histological spectrum, ranging from simple, nonprogressive steatosis to nonalcoholic steatohepatitis (NASH), which may progress to cirrhosis and hepatocellular carcinoma. While liver-related complications are confined to NASH, emerging evidence suggests both simple steatosis and NASH predispose to type 2 diabetes and cardiovascular disease. The pathogenesis of NAFLD is currently unknown, but accumulating data suggest that oxidative stress and altered redox balance play a crucial role in the pathogenesis of steatosis, steatohepatitis, and fibrosis. We will examine intracellular mechanisms, including mitochondrial dysfunction and impaired oxidative free fatty acid metabolism, leading to reactive oxygen species generation; additionally, the potential pathogenetic role of extracellular sources of reactive oxygen species in NAFLD, including increased myeloperoxidase activity and oxidized low density lipoprotein accumulation, will be reviewed. We will discuss how these mechanisms converge to determine the whole pathophysiological spectrum of NAFLD, including hepatocyte triglyceride accumulation, hepatocyte apoptosis, hepatic inflammation, hepatic stellate cell activation, and fibrogenesis. Finally, available animal and human data on treatment opportunities with older and newer antioxidant will be presented. Antioxid. Redox Signal. 15, 1325–1365. I. Introduction: Importance of Nonalcoholic Fatty Liver Disease and of Altered Redox Balance for the APathogenesis of Nonalcoholic Fatty Liver Disease A. Summary II. Free Fatty Acid Oxidation as a Source of ROS A. Overview of hepatic fatty acid oxidative pathways and their altered homeostasis in NAFLD B. Mitochondrial FA oxidation: β-oxidation C. Peroxisomal β-oxidation D. Microsomal ω-oxidation of FAs: role of cytochrome P450 enzymes in the pathogenesis of NASH E. Summary III. Lysosomal-Mitochondrial Axis as a Mediator of FFA Hepatic Lipotoxicity in NASH A. Summary IV. Modulation of Mitochondrial Function and Potential Therapeutic Implications for NAFLD A. Inhibition of ACC system B. Modulation of PPAR-γ coactivator 1α gene activity C. Modulation of PPAR-α activity D. Modulation of PPAR-γ activity E. Modulation of PPAR-δ activity F. Summary V. Adipokines in NAFLD A. Leptin B. Tumor necrosis factor-α C. Resistin D. Adiponectin E. Retinol binding protein 4 F. Renin-angiotensin system G. Interleukin-6 H. Summary VI. Mechanisms of ROS-Induced Liver Injury in NAFLD A. Inhibition of very low-density lipoprotein secretion from hepatocytes B. JNK pathway activation C. TNF-α pathway activation D. ER stress in the pathogenesis of NASH E. Role of TG cellular stores in mitochondrial dysfunction and liver injury in NASH 1. ER stress and FFA overflow to the liver 2. ER stress and hepatic de novo lipogenesis 3. ER stress and hepatic VLDL secretion F. Role of free cholesterol in mitochondrial dysfunction and liver injury in NASH G. Summary VII. UCPs and Mitochondrial Dysfunction A. Summary VIII. Mitochondrial Dysfunction as a Link Between Maternal Fat Overnutrition and NASH in Adult Offspring A. Summary IX. Myeloperoxidase Involvement in Liver Injury in NASH A. Summary X. Nitrosative Stress in the Pathogenesis of NASH A. Summary XI. Oxidized LDL and Hepatic Fibrogenesis in NAFLD A. Summary XII. Antioxidant Systems in NAFLD A. Vitamin E B. Coenzyme Q10 (ubiquinone) C. Mitochondrial MnSOD D. Mitochondrial glutathione peroxidase E. Heme oxygenase F. Summary XIII. Newer Antioxidants with Potential Therapeutic Applications in NASH A. Silibinin/silymarin B. Curcumin C. Resveratrol D. Viusid E. Summary XIV. Concluding Remarks and Future Prospects

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1089/ars.2009.3058

Cites

75 of 75 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 75 references

Cited by

See all 147

Metadata

Authors
Gambino, R., Musso, G., & Cassader, M.
Venue
Antioxidants & Redox Signaling
Published
2011-09
Volume
15
Issue
5
Pages
1325-1365
ISSN
  • 1523-0864 (ISSN-L)
  • 1557-7716
OpenAlex
W2038028850
Cited by
147
References
75
FWCI
6.50
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Redox Balance in the Pathogenesis of Nonalcoholic Fatty Liver Disease: Mechanisms and Therapeutic Opportunities. https://app.cochat.ai/papers/10.1089/ars.2009.3058
The paper
Gambino, R., Musso, G., & Cassader, M. (2011). Redox Balance in the Pathogenesis of Nonalcoholic Fatty Liver Disease: Mechanisms and Therapeutic Opportunities. Antioxidants & Redox Signaling. https://doi.org/10.1089/ars.2009.3058

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.